Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05398679 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis

Study acronym: OraPAT-IEGAMES
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Primary completion date: Oct 30, 2026 to Dec 30, 2026
    • Site details revised at 10 of 20 sites
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Jun 30, 2024 to Oct 30, 2026
    • Study sites: 1 to 20
    • Study completion date: Dec 30, 2024 to Dec 30, 2027
    • Start date changed from estimate of Jun 1, 2022 to Aug 17, 2022
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Non-inferiority trial to determine whether partial oral treatment is non-inferior to OPAT(Outpatient parenteral therapy) in patients diagnosed with infective endocarditis
Trial Details
NCT Number NCT05398679
Lead Sponsor Fundacion Clinic per a la Recerca Biomédica
Conditions
(from sponsor)		 Endocarditis Infective
Related terms Endocarditis
Enrollment 360 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov